Ganciclovir - NDC Database

14 records found
Page:1
0004-6940 Jun 23, 1989
Cytovene 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Genentech, Inc.
0143-9299 Jun 17, 2021
Ganciclovir 50 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
14335-030 Feb 11, 2019
Ganciclovir 50 mg/ml Intraventricular Injection, Powder, Lyophilized, for Solution by Hainan Poly Pharm. Co., Ltd.
25021-185 Feb 15, 2018
Ganciclovir 50 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
42023-173 Mar 31, 2017
Ganciclovir 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Par Pharmaceutical, Inc.
51754-2500 Feb 28, 2017
Ganciclovir 2 mg/ml Intravenous Injection, Solution by Exela Pharma Sciences, LLC
51817-171 Apr 24, 2018
Ganciclovir 500 mg/10ml Intravenous Injection, Solution by Pharmascience Inc.
55390-016 Dec 30, 2010
Ganciclovir 50 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
61269-450 Jun 23, 1989
Cytovene 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by H2-pharma, LLC
63304-636 Aug 27, 2003
Ganciclovir 250 mg/1 Oral Capsule by Ranbaxy Pharmaceuticals Inc.
63304-637 Aug 27, 2003
Ganciclovir 500 mg/1 Oral Capsule by Ranbaxy Pharmaceuticals Inc.
63323-315 Jun 28, 2010
Ganciclovir 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by App Pharmaceuticals, LLC
69292-015 Sep 08, 2017
Ganciclovir 1.5 mg/g Ophthalmic Gel by Amici Pharmaceuticals LLC
70436-089 Feb 11, 2019
Ganciclovir 50 mg/ml Intraventricular Injection, Powder, Lyophilized, for Solution by Slate Run Pharmaceuticals
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.